COMPANY Advanced cell / gene-based biopharmaceutical development and CDMO

Vision and Mission

Mission

To be a Leading Company in the forefront of
Well-Aging-oriented Regenerative Medicine

Vision

Innovation in Next-generation Stem Cell/ Gene Therapy
based on GMP Technology

Core Technology  /  Business Model

  • Next-Generation
    Stem Cell Therapy
    (ENCell Technology)

    Stem Cell Culture Technology producing
    high yield and potency
    Unique formulation method for cryopreservation
    Cell/Gene Therapeutics for
    Rare/Degenerative diseases

  • Mass Production using
    Core GMP Technology
    (CDMO)

    Cell/Gene Therapeutics
    CDMO
    Expertise in
    Cell Therapy Manufacturing
    and GMP operation
    GMP System Establishment in compliance
    with Global Standards

  • Targeted Gene Therapy (AAV)

    Platform with enhanced gene delivery efficiency
    AAV CDMO
    AAV gene therapy